GlassScriptPhysician profile
Salik Nazir
NPI 1194109249
$18,855.75
in general payments reported to CMS, 2019-2025
28 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2021: $550 · 2022: $330 · 2023: $7,239 · 2024: $9,453 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,937 · Food and Beverage: $7,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,937.40 |
| Food and Beverage | $7,877.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,799.93 | 2023-2024 | Supera, Xact, Perclose Prostyle |
| Medtronic, INC. | $6,142.41 | 2021-2025 | Corevalve Evolut R, Venaseal, Turbohawk |
| Inari Medical, INC. | $3,333.48 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $335.65 | 2022-2024 | Avvigo Guidance System, Ingevity+, Lux-Dx Insertable Cardiac Monitor |
| Cardiovascular Systems INC. | $266.60 | 2021-2023 | Diamondback Coronary |
| Abiomed | $197.70 | 2025 | |
| Bard Peripheral Vascular, INC. | $177.10 | 2021 | |
| Novartis Pharmaceuticals Corporation | $170.20 | 2025 | |
| Pfizer INC. | $167.26 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $159.09 | 2023-2024 | Optimizer, Optimizer |
| Amgen INC. | $157.48 | 2024-2025 | Repatha, Repatha |
| Stryker Corporation | $145.40 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.70 | 2019-2025 | Lifevest |
| Penumbra, INC. | $126.05 | 2024 | Indigo System |
| Astellas Pharma US INC | $99.99 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $62.32 | 2024 | (Br5) Peripheral Ivus |
| Kiniksa Pharmaceuticals International, Plc | $51.03 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $42.29 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $42.27 | 2022-2025 | Eliquis |
| Medtronic Vascular, INC. | $40.00 | 2019 | |
| Merck Sharp & Dohme LLC | $37.29 | 2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $34.76 | 2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $34.70 | 2024-2025 | Wainua, Farxiga |
| Bridgebio Pharma, INC. | $29.90 | 2025 | Attruby |
| Irhythm Technologies, INC. | $20.76 | 2024 | Zio Monitor, Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $17.29 | 2024 | |
| Lilly USA, LLC | $14.27 | 2025 | Mounjaro, Zepbound |
| Lexicon Pharmaceuticals, INC. | $13.83 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salik Nazir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.